Details
Stereochemistry | ACHIRAL |
Molecular Formula | K.HO |
Molecular Weight | 56.1056 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[K+]
InChI
InChIKey=KWYUFKZDYYNOTN-UHFFFAOYSA-M
InChI=1S/K.H2O/h;1H2/q+1;/p-1
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27904181 | https://www.ncbi.nlm.nih.gov/pubmed/27382594http://www.hmdb.ca/metabolites/HMDB00588Curator's Comment: description was created based on several sources, including
https://pubchem.ncbi.nlm.nih.gov/compound/sodium_ion | https://www.ncbi.nlm.nih.gov/pubmed/5107832 | https://www.drugs.com/pro/kayexalate.html | https://www.ncbi.nlm.nih.gov/pubmed/2907018
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27904181 | https://www.ncbi.nlm.nih.gov/pubmed/27382594http://www.hmdb.ca/metabolites/HMDB00588
Curator's Comment: description was created based on several sources, including
https://pubchem.ncbi.nlm.nih.gov/compound/sodium_ion | https://www.ncbi.nlm.nih.gov/pubmed/5107832 | https://www.drugs.com/pro/kayexalate.html | https://www.ncbi.nlm.nih.gov/pubmed/2907018
Sodium is the primary cation (positive ion) in extracellular fluids in animals and humans. Sodium ions are necessary for regulation of blood and body fluids, transmission of nerve impulses, heart activity, and certain metabolic functions. Physiologically, it exists as an ion in the body. Sodium is needed by animals, which maintain high concentrations in their blood and extracellular fluids, but the ion is not needed by plants. The human requirement for sodium in the diet is less than 500 mg per day, which is typically less than a tenth as much as many diets "seasoned to taste. " Most people consume far more sodium than is physiologically needed. For certain people with salt-sensitive blood pressure, this extra intake may cause a negative effect on health.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2331043 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28416444 |
|||
Target ID: CHEMBL2095186 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23284664 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | POTASSIUM HYDROXIDE Approved UseUsed as a softener for nail grooves. Also used as a slide medium in Potassium Hydroxide preparations. Apply to nail in office. Launch Date2010 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Kayexalate Approved UseINDICATION AND USAGE
Kayexalate is indicated for the treatment of hyperkalemia. Launch Date1958 |
PubMed
Title | Date | PubMed |
---|---|---|
Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. | 1991 May 15 |
|
Immunolocalization and effect of dehydration on AQP3, a basolateral water channel of kidney collecting ducts. | 1997 Feb |
|
Induction of aquaporin 3 by corticosteroid in a human airway epithelial cell line. | 1997 Nov |
|
Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. | 1998 Mar 6 |
|
Molecular characterization of a broad selectivity neutral solute channel. | 1998 Sep 18 |
|
Cloning and functional expression of rAOP9L a new member of aquaporin family from rat liver. | 1999 Feb |
|
Cr (VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions. | 2001 Jun |
|
In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis. | 2001 Mar 1 |
|
Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. | 2002 Aug 1 |
|
Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. | 2002 Feb 15 |
|
NKCC activity restores muscle water during hyperosmotic challenge independent of insulin, ERK, and p38 MAPK. | 2003 Mar |
|
Role of reactive oxygen species and Cr(VI) in Ras-mediated signal transduction. | 2004 Jan |
|
The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure. | 2006 Jan |
|
Osmotic water permeability of rat intestinal brush border membrane vesicles: involvement of aquaporin-7 and aquaporin-8 and effect of metal ions. | 2007 Dec |
|
Molecular mechanisms of how mercury inhibits water permeation through aquaporin-1: understanding by molecular dynamics simulation. | 2010 Apr 21 |
|
Aquaporins in the human testis and spermatozoa - identification, involvement in sperm volume regulation and clinical relevance. | 2010 Aug 1 |
|
Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. | 2010 Sep 6 |
|
Redox cycling and increased oxygen utilization contribute to diquat-induced oxidative stress and cytotoxicity in Chinese hamster ovary cells overexpressing NADPH-cytochrome P450 reductase. | 2011 Apr 1 |
|
Testosterone modulates pituitary vasotocin receptor expression and adrenal activity in osmotically stressed chicken. | 2011 Jan |
|
Inhibition of aquaporin-3 water channel in the colon induces diarrhea. | 2012 |
|
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters. | 2012 Jun 1 |
|
A novel aquaporin 3 in killifish (Fundulus heteroclitus) is not an arsenic channel. | 2012 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27904181
10% Potassium Hydroxide
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:23 GMT 2023
by
admin
on
Fri Dec 15 16:11:23 GMT 2023
|
Record UNII |
WZH3C48M4T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 175.210
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-525
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
||
|
CFR |
21 CFR 184.1631
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
||
|
NCI_THESAURUS |
C802
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
||
|
DSLD |
2853 (Number of products:9)
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
||
|
JECFA EVALUATION |
INS-525
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1234
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
POTASSIUM HYDROXIDE
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
14797
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
m9031
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
C029943
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
C28204
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
100000091826
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
32035
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
215-181-3
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
1310-58-3
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
WZH3C48M4T
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
34311
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB11153
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
SUB12560MIG
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
WZH3C48M4T
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
DTXSID5029633
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103983
Created by
admin on Fri Dec 15 16:11:23 GMT 2023 , Edited by admin on Fri Dec 15 16:11:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |